Tilray Brands (NASDAQ: TLRY)
Tilray Brands Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Tilray Brands Company Info
Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.
News & Analysis
1 New Reason to Consider Buying Tilray Brands Stock, and 1 New Reason to Sell
There's now a silver lining to the latest setback.
Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
Acquisitions have played a big role in Tilray Brands' strategy, and the company is still not done wheeling and dealing.
Tilray Brands Slashed Its Guidance. Is the Stock a Buy?
This worse-than-expected news is not necessarily a sign to buy the dip.
Is Tilray Brands Stock a Buy?
Despite a broad rally in cannabis, this top Canadian LP has failed to join the party.
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to Buy Tilray Brands and Canopy Growth Stock
Pot stocks can sometimes trade like meme stocks, and investors need to be careful, or they may incur significant losses.
Tilray Brands Stock vs. Bitcoin: Which Investment Is Worth the Risk?
There's a decent argument in favor of both, but only one real winner.
Where Will Tilray Stock Be in 1 Year?
Can the company finally bounce back?
3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems
Tilray Brands has been a bad buy in recent years, and that could remain the case for the foreseeable future.
Valuation
Earnings Transcripts
Tilray Brands (TLRY) Q3 2024 Earnings Call Transcript
TLRY earnings call for the period ending March 31, 2024.
Tilray Brands (TLRY) Q2 2024 Earnings Call Transcript
TLRY earnings call for the period ending December 31, 2023.
Tilray Brands (TLRY) Q1 2024 Earnings Call Transcript
TLRY earnings call for the period ending September 30, 2023.
Tilray Brands (TLRY) Q4 2023 Earnings Call Transcript
TLRY earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.